Cargando…

Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?

Detalles Bibliográficos
Autores principales:	Rubio, Jose M., Kane, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636818/ https://www.ncbi.nlm.nih.gov/pubmed/29021565 http://dx.doi.org/10.1038/s41537-017-0039-z

Ejemplares similares

O7.2. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION IN A CLINICAL COHORT
por: Rubio, Jose, et al.
Publicado: (2018)

T234. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION: A STUDY-LEVEL META-ANALYSIS AND META-REGRESSION ANALYSIS
por: Rubio, Jose, et al.
Publicado: (2018)

Is BAMM Flawed? Theoretical and Practical Concerns in the Analysis of Multi-Rate Diversification Models
por: Rabosky, Daniel L., et al.
Publicado: (2017)

The BaMM web server for de-novo motif discovery and regulatory sequence analysis
por: Kiesel, Anja, et al.
Publicado: (2018)

Publication of clinical trial protocols – what can we learn?
por: Skogvoll, Eirik, et al.
Publicado: (2013)

Neuroblastoma Mass Screening—What Can We Learn From It?
por: Katanoda, Kota
Publicado: (2016)

What can we learn from phase II adjuvant trials in melanoma?
por: Keilholz, U, et al.
Publicado: (2000)

Pressure is not a privilege: what we can learn from Simone Biles
por: Tardelli, Vitor S., et al.
Publicado: (2021)

Learning from successes: designing medication adherence intervention research so that we can learn what works and why
por: Garfield, Sara, et al.
Publicado: (2022)

Pearls collections: What we can learn about infectious disease and cancer
por: Knoll, Laura J., et al.
Publicado: (2018)

Editorial: Clustering of Schizophrenia With Other Comorbidities—What Can We Learn?
por: Mitchell, Braxton D.
Publicado: (2009)

More Evidence on the Effects of Deworming: What Lessons Can We Learn?
por: Croke, Kevin, et al.
Publicado: (2017)

Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
por: Kaufmann, Horacio
Publicado: (2017)

Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
por: Cagnazzo, Celeste, et al.
Publicado: (2020)

T23. ANTIPSYCHOTIC EXPOSURE AND STRIATAL FUNCTIONAL CONNECTIVITY IN PSYCHOSIS RELAPSE: A HYPOTHESIS GENERATING STUDY
por: Rubio, Jose, et al.
Publicado: (2020)

The Future of Pathology: What can we Learn from the COVID-19 Pandemic?
por: Williams, Bethany J, et al.
Publicado: (2020)

What can we learn from smart-pump infusion data analysis?
por: Litman, Ronald S., et al.
Publicado: (2020)

The challenge of the COVID-19 pandemic: what can we learn from history?
por: dos Santos, Vanessa Prado
Publicado: (2021)

What Can We Learn from Medical Whistleblowers?
por: Lenzer, Jeanne
Publicado: (2005)

Surgery: To what extent can we operate?
por: Kakeji, Yoshihiro
Publicado: (2018)

What can we learn from studies on regional differences in the utilization of laboratory tests?
por: Larsson, Anders
Publicado: (2011)

Where do we look for the next breakthrough in sleep research?
por: Viganò, Alessandro, et al.
Publicado: (2023)

We can do much better than what we did
por: Lee, Sang-Hak
Publicado: (2020)

Individualized Treatment Effects: Machine Learning Can Revolutionize Observations, but Let’s Understand What We Are Observing
por: Mosier, Jarrod M.
Publicado: (2023)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What we learn in time of pestilence
por: Ellaway, Rachel, et al.
Publicado: (2020)

Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines
por: Wang, Ning, et al.
Publicado: (2018)

Incontinentia pigmenti: What we know and can we manage it as retinopathy of prematurity?
por: Al-Farsi, Nouf, et al.
Publicado: (2022)

Cardiac Implantable Electronic Devices Breakthrough: Are We Ready to Face the Future?
por: Mitacchione, Gianfranco
Publicado: (2022)

Pain mechanisms in sickle cell disease. Are we closer to a breakthrough?
por: Conran, Nicola
Publicado: (2022)

Racism in science: what can we do about it?
Publicado: (2020)

The best pharmaceuticals for children—what can we do?
por: Li, Hao, et al.
Publicado: (2020)

Do Clinicians Need to Rethink Antipsychotic Maintenance Treatment?: Pro
por: Kane, J.
Publicado: (2022)

35.2 PREVENTING PSYCHOSIS: WHAT, (IF ANYTHING) CAN WE LEARN FROM THE EU-GEI INCIDENCE STUDY?
por: Jongsma, Hannah, et al.
Publicado: (2018)

The COVID-19 challenge. What have we learned?
por: Ceccato, Adrian, et al.
Publicado: (2022)

Are medical breakthroughs declining – The importance of case reports?
por: Mishra, Sundeep
Publicado: (2015)

Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't
por: Ong, Albert C M, et al.
Publicado: (2022)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

What Do We Know about Suicide Bereavement, and What We Can Do to Help Suicide-Loss Survivors?
por: Levi-Belz, Yossi, et al.
Publicado: (2023)

Bidding farewell to 2020: what lessons have we learned and what can bioethics continue to teach us?
por: Laurie, Graeme T.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n0746tpjpha8rivvv7cnrsgdvb